Next Article in Journal
Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition
Next Article in Special Issue
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating
Previous Article in Journal
Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis
Previous Article in Special Issue
Evaluation for Potential Drug–Drug Interaction of MT921 Using In Vitro Studies and Physiologically–Based Pharmacokinetic Models
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(2), 122; https://doi.org/10.3390/ph15020122
Action Date Notes Link
article xml file uploaded 20 January 2022 13:08 CET Original file -
article xml uploaded. 20 January 2022 13:08 CET Update -
article pdf uploaded. 20 January 2022 13:08 CET Version of Record https://www.mdpi.com/1424-8247/15/2/122/pdf-vor
article supplementary file uploaded. 20 January 2022 13:08 CET - https://www.mdpi.com/1424-8247/15/2/122#supplementary
article html file updated 20 January 2022 13:09 CET Original file -
article xml file uploaded 21 January 2022 02:36 CET Update -
article xml uploaded. 21 January 2022 02:36 CET Update https://www.mdpi.com/1424-8247/15/2/122/xml
article pdf uploaded. 21 January 2022 02:36 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/122/pdf
article html file updated 21 January 2022 02:37 CET Update -
article supplementary file uploaded. 26 January 2022 10:38 CET - https://www.mdpi.com/1424-8247/15/2/122#supplementary
article html file updated 26 January 2022 10:39 CET Update -
article html file updated 31 July 2022 04:57 CEST Update https://www.mdpi.com/1424-8247/15/2/122/html
Back to TopTop